Announced Fri, 29 Aug · 16:10 IST

Annual Report for the Financial Year 2024-25

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hemant Surgical Industries Ltd has filed its Annual Report for FY 2024-25 along with the Notice for its 36th Annual General Meeting, scheduled for Tuesday, September 23, 2025 at 12:30 PM via video conferencing. The company, a BSE SME-listed healthcare and medical equipment firm established in 1985, highlighted a major Government of Bihar contract for 43 ultrasound machines, 700 multi-para monitors, and 112 ECG machines under its Zoncare brand. The company is expanding with a new 1,00,000 sq ft factory in Shambhaji Nagar, Maharashtra, and growing its global footprint with offices in Uganda, Kenya, Tanzania, the Philippines, and upcoming operations in Dubai and the USA. Key AGM agenda items include re-appointment of Chairman & MD Hanskumar Shamji Shah and two whole-time directors for three-year terms, appointment of new independent directors, and ratification of cost auditor remuneration of Rs. 50,000.

Likely market impact

Routine regulatory filing with no immediate price action expected. The annual report provides shareholders with a full view of FY25 performance, while the AGM items signal leadership continuity. Investors should review the annual report for detailed financials and watch for the September 23 meeting outcomes.